Department of Otolaryngology Head and Neck Surgery, Keiyukai Sapporo Hospital, Sapporo, Japan.
Division of Endoscopy, Hokkaido University Hospital, Sapporo, Japan.
Laryngoscope. 2021 Sep;131(9):2036-2040. doi: 10.1002/lary.29524. Epub 2021 Mar 17.
OBJECTIVES/HYPOTHESIS: Transoral surgery (TOS) has become increasingly popular for patients with superficial hypopharyngeal squamous cell carcinoma (SCC). However, the number of patients in whom metachronous multiple SCC of the head and neck (HNSCC) occurs has also increased. In this study, we investigated whether multiple lugol-voiding lesions (LVLs) in the pharyngeal background mucosa observed during TOS would be a biomarker of metachronous HNSCC.
Retrospective study.
We examined 362 patients who underwent TOS for superficial hypopharyngeal carcinoma. Endoscopic images were reviewed in a blinded fashion by two endoscopists. LVLs in the pharyngeal mucosa were graded as follows: A, no lesions; B, 1 to 4 lesions; and C, ≥5 lesions per endoscopic view.
Cumulative incidence curves of secondary HNSCC in the groups of grades A, B, and C revealed 3-year incidence rates of 14.4%, 18.8%, and 29.3%, respectively (P = .001 for A vs. C and P = .002 for B vs. C). Cumulative incidence curves of third HNSCC in the groups of grades A, B. and C revealed 5-year incidence rates of 3.9%, 9.8%, and 19.6%, respectively (P = .001 for A vs. C and P = .006 for B vs. C). Cumulative incidence curves of fourth HNSCC in the groups of grades A, B, and C revealed 7-year incidence rates of 0%, 2.3%, and 13.2%, respectively (P = .025 for A vs. C and P = .009 for B vs. C).
Multiple LVLs in the pharyngeal mucosa increase the risk of development of metachronous multiple HNSCC.
3 (nonrandomized, controlled cohort/follow-up study) Laryngoscope, 131:2036-2040, 2021.
目的/假说:经口手术(TOS)已成为治疗浅表下咽鳞状细胞癌(SCC)患者的首选方法。然而,同时发生头颈部(HNSCC)多处 SCC 的患者数量也有所增加。在本研究中,我们探讨了 TOS 中观察到的咽黏膜多发卢戈氏碘染色缺失(LVL)是否为发生同步性 HNSCC 的生物标志物。
回顾性研究。
我们对 362 例行 TOS 治疗的浅表下咽癌患者进行了研究。由两名内镜医生对内镜图像进行盲法评估。咽黏膜 LVL 分级如下:A,无病变;B,1-4 个病变;C,每个内镜视野下≥5 个病变。
A、B 和 C 级组的继发性 HNSCC 累积发生率曲线显示,3 年累积发病率分别为 14.4%、18.8%和 29.3%(A 级与 C 级比较,P=0.001;B 级与 C 级比较,P=0.002)。A、B 和 C 级组的第 3 次 HNSCC 累积发生率曲线显示,5 年累积发病率分别为 3.9%、9.8%和 19.6%(A 级与 C 级比较,P=0.001;B 级与 C 级比较,P=0.006)。A、B 和 C 级组的第 4 次 HNSCC 累积发生率曲线显示,7 年累积发病率分别为 0%、2.3%和 13.2%(A 级与 C 级比较,P=0.025;B 级与 C 级比较,P=0.009)。
咽黏膜多发 LVL 增加了发生同步性多处 HNSCC 的风险。
3(非随机、对照队列/随访研究)《喉镜》,131:2036-2040,2021。